Childhood asthma and GOLD-defined chronic obstructive pulmonary disease

Internal Medicine Journal

Volumn 42, Issue 1, 2012, Pages 83-88

  Shirtcliffe, P ^a,b   Marsh, S ^a   Travers, J ^a   Weatherall, M ^b,c   Beasley, R ^a,b  

^a Medical Research Institute   (New Zealand)

^b CAPITAL AND COAST DISTRICT HEALTH BOARD   (New Zealand)

^c UNIVERSITY OF OTAGO   (New Zealand)

Author keywords

Asthma; COPD; Risk factor

Indexed keywords

ADULT; AGED; ARTICLE; ASTHMA; ATOPY; CHILDHOOD DISEASE; CHRONIC OBSTRUCTIVE LUNG DISEASE; CIGARETTE SMOKING; COUGHING; EMPHYSEMA; FEMALE; FORCED EXPIRATORY VOLUME; FORCED VITAL CAPACITY; HUMAN; LUNG FUNCTION TEST; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; PHLEGMON; PREVALENCE; PRIORITY JOURNAL; QUESTIONNAIRE; RISK FACTOR; SMOKING; WHEEZING;

ADULT; AGED; ASTHMA; BRONCHITIS; CHILD; COMORBIDITY; DISEASE PROGRESSION; FEMALE; HUMANS; HYPERSENSITIVITY, IMMEDIATE; MIDDLE AGED; NEW ZEALAND; OCEANIC ANCESTRY GROUP; PREVALENCE; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; PULMONARY EMPHYSEMA; RISK FACTORS; SAMPLING STUDIES; SKIN TESTS; SMOKING; SPIROMETRY;

EID: 84856296569     PISSN: 14440903     EISSN: 14455994     Source Type: Journal    
DOI: 10.1111/j.1445-5994.2010.02238.x     Document Type: Article

References (29)

1. Rabe KF, Hurd S, Anzueto A, Barnes PJ, Buist SA, Calverley P etal. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease. GOLD executive summary. Am J Respir Crit Care Med 2007; 176: 532-55.
2. Mannino D, Buist S. Global burden of COPD: risk factors, prevalence, and future trends. Lancet 2007; 370: 765-73.
3. Rennard S, Vestbo J. COPD: the dangerous underestimate of 15%. Lancet 2006; 367: 1216-19.
4. Lundback B, Lindberg A, Lindstrom M, Ronmark E, Jonsson AC, Jonsson E etal. Not 15 but 50% of smokers develop COPD? - Report from the Obstructive Lung Disease in Northern Sweden Studies. Respir Med 2003; 97: 115-22.
5. Marsh S, Aldington S, Shirtcliffe P, Weatherall M, Beasley R. Smoking and COPD: what really are the risks? Eur Respir J 2006; 28: 883-4.
6. Salvi S, Barnes P. Chronic obstructive pulmonary disease in non-smokers. Lancet 2009; 374: 733-43.
7. COPD - more than just tobacco smoke [editorial]. Lancet 2009; 374: 663.
8. Sluiter HJ, Koeter GH, de Monchy JG, Postma DS, de Vries K, Orie NG. The Dutch hypothesis (chronic non-specific lung disease revisited). Eur Respir J 1991; 4: 479-89.
9. Kraft M. Asthma and chronic obstructive pulmonary disease exhibit common origins in any country! Am J Repsir Crit Care Med 2006; 174: 238-40.
10. Barnes P. Against the Dutch hypothesis: asthma and chronic obstructive pulmonary disease are distinct diseases. Am J Respir Crit Care Med 2006; 174: 240-3.
11. Postma D, Boezen M. Rationale for the Dutch hypothesis. Chest 2004; 126: 96S-104S.
12. Shirtcliffe P, Weatherall M, Marsh S, Travers J, Hansell A, McNaughton A etal. COPD prevalence in a random population study: a matter of definition. Eur Respir J 2007; 30: 232-9.
13. Marsh S, Aldington S, Williams M, Kingzett-Taylor A, Weatherall M, Shirtcliffe P etal. Physiological associations of computerized tomography lung density: a factor analysis. Int J COPD 2006; 1: 181-7.
14. Marsh S, Aldington S, Williams M, Nowitz M, Weatherall M, Shirtcliffe P etal. Complete reference ranges for pulmonary function tests from a single New Zealand population. NZMJ 2006; 119.
15. Global Initiative for Asthma (GINA). Global strategy for asthma management and prevention. 2004; [cited 2009 Nov 17]. Available from URL:.
16. Yernault J. The birth and development of the forced expiratory manoeuvre: a tribute to Robert Tiffeneau (1910-1961). Eur Respir J 1997; 10: 2704-10.
17. Calverley P, Kerstjens H. The GOLD classification has advanced understanding of COPD. Am J Respir Crit Care Med 2004; 170: 211-14.
18. Hardie JA, Buist AS, Vollner WM, Ellingsen I, Bakke PS, Morkve O. Risk of over-diagnosis of COPD in asymptomatic elderly never-smokers. Eur Respir J 2002; 20: 1117-22.
19. Calverley PM, Burge PS, Spencer S, Anderson JA, Jones PW. Bronchodilator reversibility testing in COPD. Thorax 2003; 58: 659-64.
20. ATS/ERS Task Force. Standards for the diagnosis and treatment of patients with COPD: a summary of the ATS/ERS position paper. Eur Respir J 2004; 23: 932-46.
21. British Thoracic Society, Scottish Intercollegiate Guidelines Network. British guideline on the management of asthma. Thorax 2003; 58(Suppl I): i1-94.
22. Sears MR, Greene JM, Willan AR, Wiecek EM, Taylor DR, Flannery EM etal. A longitudinal population-based cohort study of childhood asthma followed to adulthood. N Engl J Med 2003; 349: 1414-22.
23. Guerra S. Overlap of asthma and COPD. Curr Opin Pulm Med 2005; 11: 7-13.
24. Sciurba F. Physiologic similarities and differences between COPD and asthma. Chest 2004; 126: 117S-24S.
25. Marsh SE, Travers J, Weatherall M, Williams MV, Aldington S, Shirtcliffe PM etal. Proportional classifications of COPD phenotypes. Thorax 2008; 63: 761-7.
26. Lange P, Parner J, Vestbo J, Schnohr P, Jensen G. A 15-year follow-up study of ventilatory function in adults with asthma. N Engl J Med 1998; 339: 1194-200.
27. Silva G, Sherrill D, Guerra S, Barbee R. Asthma as a risk factor for COPD in a longitudinal study. Chest 2004; 126: 59-65.
28. Weatherall M, Travers J, Shirtcliffe PM, Marsh SE, Williams MV, Nowitz MR etal. Distinct clinical phenotypes of airways disease defined by cluster analysis. Eur Respir J 2009; 34: 812-18.
29. Gibson P, Simpson J. The overlap syndrome of asthma and COPD: what are its features and how important is it? Thorax 2009; 64: 728-35.